TheEdgeResearch
Home / Stocks / SHWGF

Shandong Weigao Group Medical Polymer Company Limited (SHWGF)

OTC Healthcare Medical - Instruments & Supplies
$0.42 ▲ +0.00%
Market Cap
$1.87B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
0.37
52-Wk Range
0.42-0.76
CEO
Rinan Cong
Country
CN
Currency
USD

Shandong Weigao Group Medical Polymer Company Limited operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Weihai, SD, CN. The stock last traded at $0.42, up 0.00% on the session, giving a market capitalisation of $1.87B. On trailing twelve-month figures it carries a trailing P/E of 8.34, a net margin of 12.0%. Its beta of 0.37 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
8.34
Price / Sales
0.97
Price / Book
0.56
EV / EBITDA
3.62
Gross margin
47.3%
Operating margin
12.7%
Net margin
12.0%
Return on equity
Debt / equity
0.25
Current ratio
3.78
Dividend yield
5.2%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
13,307
IPO date
2010-06-08
Headquarters
Weihai, SD, CN
About Shandong Weigao Group Medical Polymer Company Limited

Shandong Weigao Group Medical Polymer Company Limited, established in Weihai, People's Republic of China, in 2000, operates as a comprehensive entity focused on the research, development, manufacturing, and sale of a wide array of medical devices, primarily single-use, across the PRC. The company's operations are structured into several distinct segments, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, and Blood Management Products. Its extensive product portfolio includes essential medical consumables such as infusion devices for both vascular and non-vascular access, infusion sets, syringes, puncture needles, and specialized clinical collection kits. Shandong Weigao also provides wound care solutions like sutures and healing dressings, alongside equipment for blood collection, storage, separation, and sterilization. Beyond these, the company's offerings encompass prefilled and pre-flush syringes, blood glucose testing devices, a full range of anesthesia consumables (general, local, and auxiliary), ICU equipment, and surgical instruments for both open and minimally invasive procedures. It is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, implantation materials, and artificial organs. Furthermore, the company manufactures medical PVC granules, various plastic packing materials, carton boxes, industrial automation equipment, molds, and hemodialysis equipment, encompassing Type I, Type II, and Type III medical devices. Complementing its core manufacturing, Shandong Weigao extends its services to finance leasing and factoring, wholesale distribution of various medical devices (including surgical and other disposable products), asset management, enterprise consulting, and logistics and storage. The company also engages in exporting its products, which are marketed under well-known brands such as Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing. Its diverse clientele includes hospitals, blood stations, other medical units, and distributors.

Comparable companies

Shandong Weigao Group Medical Polymer Company Limited is most often compared with the following Healthcare names:

ANSLFANSLYBVNKFBVNRYMAHLYMEPDFRGEDFRHCGFTCGGYTCHBF
More research on SHWGF
SHWGF technical analysis SHWGF TheEdge Score Compare against peers
Open full interactive analysis & DCF →